0001209191-17-033761.txt : 20170518 0001209191-17-033761.hdr.sgml : 20170518 20170518203309 ACCESSION NUMBER: 0001209191-17-033761 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170517 FILED AS OF DATE: 20170518 DATE AS OF CHANGE: 20170518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brockstedt Dirk G. CENTRAL INDEX KEY: 0001635616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 17856247 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-17 0 0001435049 ADURO BIOTECH, INC. ADRO 0001635616 Brockstedt Dirk G. C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710 0 1 0 0 EVP of Research and Dev. Common Stock 2017-05-17 4 S 0 1011 9.65 D 49300 D The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2016. Includes 1,011 shares acquired by the Reporting Person on May 15, 2017 under the Issuer's 2015 Employee Stock Purchase Plan. /s/ Jennifer Lew, Attorney-in-Fact 2017-05-18